English » Lab Profile » Lab Members » MSc

MSc

MSc Clinical Chemistry 

  1. L. Mpathrellos: Development of immunoenzymic method for the determination of Interleukin-6 (IL-6) in biological fluids by fluorimetric detection, 1997
  2. K. Petrovas: Development of immunoenzymic method for the determination of Tumour Necrosis Factor-α (TNF-α) in biological fluids by fluorimetric detection, 1998
  3. S. Ntaskas: Optimization and applications of immunoenzymic method for the determination of Tumour Necrosis Factor-α (TNF-α) in biological fluids, 1998
  4. A. Gyzi: Development and clinical applications of cytokeratin-19 (CK-19) mRNA quantitative determination method in breast cancer patients peripheral blood, 2002
  5. A. Spyropoulou: Clinical applications of human telomerase reverse transcriptase (hTERT) determination methods, 2002
  6. M. Ntoulia: Development of mammaglobin mRNA quantitative determination method by real-time  RT-PCR and clinical applications in breast cancer patients, 2003
  7. E. Zygalaki: Development and clinical applications of method for the quantitative determination of Vascular Endothelial Growth Factor (VEGF) mRNA by real-time RT-PCR, 2003
  8. N. Ioannidou: Quantitative determination of BRCA1 mRNA by real-time PCR in sporadic breast cancer, 2005
  9. A. Pavlidou: Development and clinical applications of real-time RT-PCR for the quantitative determination of carcinoembryonic antigen mRNA, 2004
  10. Ε. Mavrogiannou: Development and clinical applications of methodology for the quantitative determination of 4 alternative splicing products of human telomerase reverse transcriptase by real-time RT-PCR, 2005
  11. A. Strati: Expression study of human telomerase reverse transcriptase (hTERT) splice variants by real-time RT-PCR in Non Small Cell Lung Cancer (NSCLC) and in cancer cell line MCF-7, 2006
  12. M. Kioulafa: Study for the prognostic significance of RASSF1A, CST6 and hK10 in primary breast cancer, 2007
  13. P. Vorkas: Development and clinical evaluation of mutation analysis methods by High-Resolution Melting Analysis and fluorimetric detection, 2008
  14. Maria Chimonidou: Methylation study of tumor suppressor genes in circulating tumor cells (CTCs), 2010
  15. C. Parisi: Development and clinical evaluation of analytical methodology for the study of gene expression of VEGF splice variants based on liquid bead array technology, 2010
  16. Lampros Dimitrakopoulos: Development and clinical evaluation of methodology for the detection of CST6 and BRCA1 methylation by High Resolution Melting Analysis (MS-HRMA), 2010
  17. Christina Schiza: Development and applications of highly sensitive mutation analysis methods based on High-Resolution Melting Analysis (HRMA) and ARMS-PCR, 2011
  18. Sofia Farkona: Mutation analysis of the PIK3CA gene in breast cancer, 2011
  19. Antonia Efstathiou: Development and clinical application of mutation analysis methods of PIK3CA and BRAF using ARMS-PCR and High-Resolution Melting Analysis (HRMA), 2012
  20. Lydia Giannopoulou: DNA methylation study of SOX17 and CST6 genes promoters in ovarian cancer, 2014
  21. Sophia Mastoraki: DNA methylation study and clinical evaluation of SOX17 and BRMS1 promoters in breast cancer using high resolution melting analysis (MS-HRMA), 2014
  22. Eleni Tzanikou: Development and clinical application of methods for mutations detection in BRAF and ESR1 combining ARMS-PCR and high resolution melting analysis (HRMA), 2014
  23. Ilias Angelidis: Study of the androgen receptor expression and its splice variants in CTCs in prostate cancer, 2015
  24. Μaria-Filothei Lazaridou: Study of the expression of PLASTIN-3 and methylation study of RASSF1A in samples of breast cancer and prostate cancer patients, 2015
  25. Panagiotis Paraskevopoulos: Molecular characterization of CTCs in early prostate cancer patients, 2015
  26. Aliki Ntzifa: Expression study of androgen receptor and androgen receptor's splice variants in circulating tumor cells and tissue samples of breast cancer patients, 2016
  27. Sophia Melliou: PD-L1 gene expression on circulating tumor cells of patients with metastatic breast cancer, 2018
  28. George Bendo: DNA methylation study of GSTP1 and RASSF1A in circulating tumor cells of patients with early prostate cancer, 2019
  29. Stavroula Smilkou: Detection of gene transcripts in plasma cell free RNA of patients with non-small cell lung cancer, 2019
  30. Konstantina Georgitsopoulou, DNA methylation study of NR2F1 in breast and ovarian cancer, 2019
  31. Ailda Gjordumi, DNA methylation study of GSTP1, BRCA1 and CST6 in breast cancer patients, 2019
  32. Victoria Tserpeli, DNA methylation study of SOX17, MGMT and MLL3 in circulating tumor cells of patients with early prostate cancer, 2019 

 

MSc Clinical Biochemistry - Molecular Diagnostics 

  1. E. Papadimitriou: Study of isolation and quantitative determination of circulating tumour cells in peripheral blood by real-time PCR, 2005
  2. V. Giannikopoulos: Study of RASSF1A and BRCA1 methylation in breast cancer, 2006
  3. P. Triantafylloy: Evaluation of prognostic significance of new molecular markers for DNA methylation (RASSF1A, CST6 and KLK10) in Non Small Cell Lung Cancer, 2007
  4. C. Theodoropoulos: Study of BETAIG-3h methylation in Non Small Cell Lung Cancer, 2007
  5. I. Balgkouranidou: Evaluation of prognostic significance of APC and SOX17 methylation in Non Small Cell Lung Cancer, 2008
  6. E. Kosmidou: Clinical evaluation of microRNAs as new molecular markers in Non Small Cell Lung Cancer (real-time PCR methodology), 2008
  7. A. Tzitzira: Clinical evaluation of CST6 methylation as a novel tumor biomarker, 2009
  8. A. Konstantinidou: Study of the expression of TWIST-1 in Non Small Cell Lung Cancer, 2009
  9. E. Markaki Methylation study of RASSF1A, BRMS1 and SOX17 in colon cancer patients, 2013
  10. A. KotsifisStudy of the clinical importance of plasma circulating miRs, miR-21 and let-7a in colon cancer patients, 2013
  11. Martha Zavridou: Study of plasma circulating microRNAs in cancer patients, 2014
  12. Vanessa Valiakou: Detection of mutations in PIK3CA (exon 9 - exon20) by combining ARMS-PCR and High Resolution Melting Analysis (HRMA) in non-cancerous tissues and procancerous lessions of the breast, 2015
  13. Κyriaki Mavraki:  Study of DNA methylation of BRMS1, CST6 and RASSF1A in procancerous lessions of the breast and study of DNA methylation of RASSF1A in breast cancer, 2015
  14. Chrysanthi Panteli, 2019


MSc Analytical Chemistry:

  1. M. Kolioliou: Development of PCR-ELISA method for the determination of telomerase activity in biological samples, 2000
  2. G. Tsiagkas: Development of mutation analysis methods (SSCP, TTGE) for mutation screening in BRCA-1 in Greek population, 2001